Clinical Trials Directory

Trials / Completed

CompletedNCT04542577

PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D

Multicenter PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D - A Prospective Study on Total Indications

Status
Completed
Phase
Study type
Observational
Enrollment
208 (actual)
Sponsor
Aesculap AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, pure data collection of all PROSPACE 3D, PROSPACE 3D Oblique, TSPACE 3D patients in selected centers (not interventional, multicenter

Detailed description

The study collects a data set for each patient receiving a PROSPACE 3D, PROSPACE 3D Oblique, or TSPACE 3D implant. It is intended to collect data preoperatively, intraoperatively and at one follow-up- assessment after a minimum of one year postoperatively containing * Basic medical history * Type of surgical procedure * Treated segments * Implant characteristics (including additional implants for anterior/posterior stabilization) * Scores: ODI, Pain (VAS), EQ-5D * Patient satisfaction

Conditions

Timeline

Start date
2020-09-23
Primary completion
2023-01-09
Completion
2024-01-25
First posted
2020-09-09
Last updated
2024-12-18

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04542577. Inclusion in this directory is not an endorsement.